GLP-1 medications for weight: what they are and how they work

GLP-1 medications have changed how clinicians approach weight, but the names get thrown around without much explanation. Here is a straightforward look at what they are and how a licensed provider decides whether one is appropriate.

What GLP-1 medications are

GLP-1 stands for glucagon-like peptide-1, a natural signal your gut releases after you eat. Medications in this class mimic that signal. Semaglutide acts on the GLP-1 pathway; tirzepatide acts on GLP-1 and a second pathway called GIP. Both are prescription medications, given as a weekly injection or, in some protocols, other forms.

How they work

• They slow how quickly the stomach empties, so you feel full longer after a meal.
• They reduce appetite and the constant background of food cues for many people.
• They support steadier blood-sugar and insulin response, which is why some were first developed for type 2 diabetes.

FDA-approved vs. compounded

Some GLP-1 products are FDA-approved brand medications. Others are compounded preparations made by licensed US pharmacies under FDA-regulated 503A or 503B authority. A compounded formulation has not undergone separate FDA approval. A provider will tell you which is which, and FDA-approved options may be available.

What a provider weighs before prescribing

A GLP-1 is not right for everyone. Before prescribing, a licensed provider reviews your health history, current medications, and any conditions that would make the medication unsafe. They set realistic expectations and go over side effects, which commonly include nausea, especially early on. Not everyone is approved, and that review is the point.

Results vary from person to person and depend on dose, adherence, diet, and activity. No specific outcome is guaranteed, and a GLP-1 works best alongside, not instead of, sustainable habits.